Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 18 Aug 2026
Not all adrenal incidentalomas need the same workup. The Curbsiders break down when to worry, what to test, and why MACS may be behind your patient's hard-to-control metabolic disease.
Read Full NewsBritish lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...
In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.
Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.
Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.
In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.
For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.
1.
In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.
2.
Early Tislelizumab May Boost PFS in Esophageal Cancer
3.
Patients with head and neck cancer who cannot receive cisplatin now have new hope.
4.
Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?
5.
How to keep your prostate healthy and lower your risk of developing serious problems
1.
Tumor Microenvironment Mapping in Cancer Care
2.
Pharmacokinetic Variability in Hematologic Disorders: Mechanisms, Clinical Implications, and Evidence-Based Approaches
3.
Polycythemia Vera: A Historical Perspective and Contemporary Management
4.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
5.
Bone Marrow Functional Reserve Screening in Healthy Aging
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
3.
Early Cancer Detection Saves Lives
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge